EXCLUSIVE- CHINA'S NATIONAL MEDICAL PRODUCTS ADMINISTRATION IN LATE DECEMBER MET WITH SEVERAL CHINESE DRUGMAKERS INCLUDING ZHEJIANG HUAHAI PHARMACEUTICAL AND CSPC PHARMACEUTICAL GROUP TO DISCUSS PREPARATIONS NEEDED TO MAKE A GENERIC VERSION OF PAXLOVID -SOURCE